Brazil maintains 95% vaccination coverage over the last 10 years

4 November 2012

Vaccination coverage in Brazil over the last 10 years has averaged 95% for most vaccines on the child immunization schedule and in vaccination campaigns, according to a government press notice. Vaccines are made freely available in the 35,000 public health care units. Maintaining child immunization schedules up to date ensures health and helps Brazil to continue registering high rates of vaccination coverage against vaccine-preventable diseases.

Brazil’s National Immunization Program (PNI) from the Ministry of Health has established schedules not only for the first year of life, but also for children, teenagers, adults and senior citizens. "Brazil has one of the best and most complex immunization programs in the world, offering vaccines against a range of diseases, free of charge. The vaccine is an important ally to control, combat and eliminate these diseases and Brazil is a model for other countries that have not managed to achieve vaccination coverage such as ours," said Jarbas Barbosa, Secretary of Health Monitoring.

As an example, in 2011, the BCG vaccine against tuberculosis achieved 107.7% vaccine coverage; the MMR vaccine against measles, mumps and rubella achieved 102.2% and meningococcal conjugate C, included in the schedule in 2011, achieved 105.5% vaccination coverage. In 2012, during the polio vaccination campaign for children under five years of age, more than 14 million children were vaccinated, attaining vaccination coverage of 98%. Vaccination campaigns against influenza also show the mobilization capacity of the PNI in terms of the population adhering to the call for vaccination. This year, more than 25 million vaccines were registered and total coverage reached 86.24% of the target population, estimated at around 30 million people.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical